Nonsteroidal anti-inflammatory drugs in early pregnancy.
about
Teratogenic mechanisms of medical drugsPain Management in Pregnancy: Multimodal ApproachesDrugs associated with teratogenic mechanisms. Part II: a literature review of the evidence on human risksCongenital ventricular septal defects and prenatal exposure to cyclooxygenase inhibitorsHuman pregnancy safety for agents used to treat rheumatoid arthritis: adequacy of available information and strategies for developing post-marketing dataExposure to non-steroidal anti-inflammatory drugs during pregnancy and the risk of selected birth defects: a prospective cohort studyDysmorphic child born after maternal diclofenac therapy.Major malformations after first trimester exposure to aspirin and NSAIDs.Stress and dysmenorrhoea: a population based prospective studyCase-control analysis of maternal prenatal analgesic use and cardiovascular malformations: Baltimore-Washington Infant StudyPregnant women and non-steroidal anti-inflammatory drugs: knowledge, perception and drug consumption pattern during pregnancy in ethiopiaDescriptive and risk factor analysis for choanal atresia: The National Birth Defects Prevention Study, 1997-2007Effects of ibuprofen, diclofenac, naproxen, and piroxicam on the course of pregnancy and pregnancy outcome: a prospective cohort study.The safety of ketoprofen in different ages.The use of antirheumatic disease drugs during pregnancy.Migraine therapy during pregnancy and lactation.Pharmacogenetics of drug-induced birth defects: what is known so far?Outcomes after anti-rheumatic drug use before and during pregnancy: a cohort study among 150,000 pregnant women and expectant fathers.When one drug affects 2 patients: a review of medication for the management of nonlabor-related pain, sedation, infection, and hypertension in the hospitalized pregnant patient.An update in the treatment of neurologic disorders during pregnancy--focus on migraines and seizures.Ongoing Pharmacological Management of Chronic Pain in Pregnancy.Development of A Machine Learning Algorithm to Classify Drugs Of Unknown Fetal EffectPharmacological treatment of migraine during pregnancy and breastfeeding.Prescribing of NSAIDs and ASA during pregnancy; do we need to be more careful?Nonsteroidal antiinflammatory drug use among women and the risk of birth defects.Use of antihistamine drugs in early pregnancy and delivery outcome.Final results from the 16-year sumatriptan, naratriptan, and treximet pregnancy registry.Exposure to cox-2 inhibitors (coxibs) during the first trimester and pregnancy outcome: a prospective observational cohort study.The Impact of Nondifferential Exposure Misclassification on the Performance of Propensity Scores for Continuous and Binary Outcomes: A Simulation Study.Risk comparison for prenatal use of analgesics and selected birth defects, National Birth Defects Prevention Study 1997-2011.Effects of prenatal exposure to diclofenac sodium and saline on the optic nerve of 4- and 20-week-old male rats: a stereological and histological study.Prescription drugs during pregnancy and lactation--a Finnish register-based study.The effect of flurbiprofen on the development of anencephaly in early stage chicken embryos.
P2860
Q22337136-FC4BDD38-E92A-445D-A00B-04117E784EFDQ26785973-8F0CBB87-980D-484D-B1F3-633DA3D77A13Q26991704-5360AF6F-2DEF-45F3-975E-01D007F90D0BQ28199711-FCA360F8-09FD-4D45-99AF-8A6CF585A3AAQ31044246-654DF52D-E141-4FB4-AC84-86868BAB6891Q33971337-9ED6388D-A8F2-4766-A243-F1B6FB2D8DF6Q34844255-E210249B-3232-44E7-A895-B75B0035FBD6Q35085118-477808C7-23B4-4910-A1AE-B0A293717E0FQ35500137-C591DDE7-3AB2-49DF-B4BB-B207D031FA69Q35525008-67E4C88D-A6AB-47C3-AE61-851474795B32Q35811049-F0F89E82-2804-4C73-809E-A6E81529EEC8Q35903277-C98230E6-6B5C-4B19-986C-B5B81668FC80Q36930421-BA1B8E71-8C37-48FA-9259-E11FCE6124E4Q37369689-391BA39C-16E2-4239-BA9F-DD421A696FE7Q37608422-C6F507FA-DD89-435A-9EBB-A8394BF3909CQ37775960-1CACB166-F435-4979-8B2C-42069509A11DQ37869124-5E9A0578-2353-4324-A462-DD28867B6601Q37991751-0BF26090-250F-43D1-83D8-9CDA4679B3FDQ38006442-BEBC50B9-C71C-45A1-A860-25F5635A2344Q38006916-748ADAB8-2B8C-4E1B-B802-3DABC8C880B7Q38827847-F00AC317-12C0-4BC1-BF17-18A15E6C8AEEQ42373894-67BF3730-23E0-4026-830A-1E8BEEB22241Q43063871-86C763A7-2210-48DA-8B85-F1A1B4F97385Q43110252-93762D27-7DEC-4645-ACD2-BA995A625ACFQ43572859-C4EE7279-3C3B-4CE2-B098-B75120AA51C6Q44179729-7009CB04-BEE2-4E2D-9764-000D7A4A2B30Q46004711-E40A14F7-1BAE-4CD9-BF84-D3879E7F74FFQ47353855-5C04FD64-C6FE-4FD1-84A3-875BD00C1E39Q47683159-67ACFA35-E43E-4589-B36B-88622D7C7F85Q47833785-745CDD59-E8D3-4103-847C-256993715015Q47843575-65B9E2D3-8FEF-4143-ADA1-4499CB335BFFQ47967749-C88DCB14-A2EB-4D8B-A0F7-3078AE16BF47Q52654752-F94E85EA-4337-4422-A723-7BFCE6573D1D
P2860
Nonsteroidal anti-inflammatory drugs in early pregnancy.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh-hant
name
Nonsteroidal anti-inflammatory drugs in early pregnancy.
@en
Nonsteroidal anti-inflammatory drugs in early pregnancy.
@nl
type
label
Nonsteroidal anti-inflammatory drugs in early pregnancy.
@en
Nonsteroidal anti-inflammatory drugs in early pregnancy.
@nl
prefLabel
Nonsteroidal anti-inflammatory drugs in early pregnancy.
@en
Nonsteroidal anti-inflammatory drugs in early pregnancy.
@nl
P1476
Nonsteroidal anti-inflammatory drugs in early pregnancy.
@en
P2093
P304
P356
10.1016/S0890-6238(01)00137-X
P577
2001-07-01T00:00:00Z